We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mporium Group Plc | LSE:MPM | London | Ordinary Share | GB00BGDW0L56 | ORD 0.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
30/3/2007 10:43 | i am very happy to stick with minster - | harry punter | |
30/3/2007 10:43 | you think i am dreaming or totally mad even both -- your right -i am -but it only takes one approved drug to put MpM on the map -too much time money and R&D has already been spent --for this to stumble at the last hurdle -- besides it's GSK 's reputation thats on the line -and i back them above all the other major pharma's | harry punter | |
30/3/2007 07:11 | IMHO within two years we will get our FDA approval for our compouds and by then --our shares should quite easily be trading around the £5-£7plus level--in this format \o/ regards harry and the boys in dark glasses | harry punter | |
29/3/2007 07:49 | its all about regulatory approval or even joint venture partnerships - | harry punter | |
28/3/2007 15:51 | How long will it take for the share price to be 1.5p again? I have seen this many times before and am concerned at this situation. Anybody out their with a more possitive outlook please feel free to reply. | ssmith4 | |
28/3/2007 04:03 | MpM market cap is well over £40 mill now---we have distribution rights for two GSK compounds -- decent brokers and financial advisers----- plenty of institutional share investors (I mean punters) to give us all the cash we need to get us into the billion pound plus global market place \o/ --all we really need now is regulatory approval -----no probs punters \o/ £5.00sp here we come \o/ regards harry and the boys in dark glasses ps Nasdaq listing next year | harry punter | |
21/3/2007 19:50 | Well is not the new deal going well? | vuelands | |
10/3/2007 07:53 | i myself, certainly agree with that jimmy | harry punter | |
09/3/2007 11:48 | Whilst I admit to having a vested interest in this share, I really feel that the sea change over the last week, with our new investors coming on board and the share consolidation bodes well....upstream this is not intended for penny investors, more for serious players imo | jimmyloser | |
08/3/2007 10:42 | spitfire i am not getting up tight on any share dilution -considering this is a heaven or hell share ie either Minster is worth nothing or a fortune with regulatory approval or not -- dont forget these two GSK compounds approx £500million has already been spent on R&D -and with these company shares valued a mere £24ml -- | harry punter | |
08/3/2007 09:17 | spitfire --i am self employed -and very soon i will be publishing my auto-biography on life in the city -i hope this will become a best seller -- in the meantime -i have a personal axe to grind with the Imro and the SFA regulators for being totally responsible for allowing Gary Amos and Steve Regan to continue to operate there money laundering and insider dealing scams --one of the indiviuals is closely connected and involved with the notorious ADAMS CRIME SNDICATE -i reported this to Les Hughs enforcement officer at the SFA in 2000 | harry punter | |
08/3/2007 08:18 | harry everyone is aware of your mental history...they read your posts....lets talk about massive dilution and not the mafia...and why you ramp this up...who pays you to ramp it up...hedge fund or institution..??? | spitfire3 | |
08/3/2007 08:15 | Diana's Story 1967 Went to university. 1968 Bad car crash. Nearly died. Finally gave up on God. 1969 Got married and went to live in a commune. 1972 Gained first class honours degree in psychology - as well as an identity as a mental patient by taking my exams in an acute psychiatric unit. 1976 Got a lecturing job and met my partner. 1986 Medically retired from teaching. Told never to seek work again. 1987 First mental health service user meeting. A revelation. 1990 Started PhD on 'media representations of madness'. 1995 Offered a job at the Sainsbury Centre for Mental Health. 1996 Got my PhD. 1999 Spent the whole year 'sectioned' under the Mental Health Act. But my job is kept open, so I can continue my double life as a researcher and mental patient. Decide the latter has its upside... "I'm an academic, although I've had a pretty strange career. I think getting a good education was my way of escaping a traumatic childhood. I went to university when I was seventeen. When I was there I started hearing voices, and I put my head in a gas oven. At the time, it was awful - but I still managed to get a first class degree. I remember I was like a walking chemical experiment when I sat my final exams. That was the start of a long-term struggle - with mood swings, self-harm, and hearing voices at the worst times. Still, I went on to do some really interesting jobs in universities. Then I had one particularly bad period and was medically retired from teaching. My health worker said I shouldn't do 'stressful' work again. So I spent years being unemployed and doing clerical work. This is where one of the most insidious aspects of discrimination comes in, because I think one of the worst things is people's low expectations. I had good qualifications but they seemed to count for nothing. Luckily, I became involved with the mental health survivor movement, and I finally landed a research job. I think after 20 years looking for a "cure" I've reached a kind of accommodation with my illness. I've come to think of mental health problems as something you can learn from. They can help you make a contribution in the world. Discrimination - my experience: I believe very strongly in challenging discrimination. I think it's outrageous that I can't sit on a jury, can't get a mortgage with my partner because I can't get life insurance, and can't get a driving licence if I've been in hospital within the last two years. Every time I need insurance - even just for a holiday - it's a problem, or I get charged higher premiums. I really don't think I'm any more of a risk than other people. Perhaps one of the scariest incidents of discrimination was when our flat was burgled. We lost everything. I wanted the police to investigate the people downstairs, who I was sure were involved. But they said they couldn't investigate because my mental history meant I wasn't a credible witness. It seemed to me I just wasn't getting justice." | harry punter | |
08/3/2007 08:03 | Drug firms a danger to health - report International research exposes flaws in £33bn marketing budget Sarah Boseley, health editor Monday June 26, 2006 Guardian Drug companies are accused today of endangering public health through widescale marketing malpractices, ranging from covertly attempting to persuade consumers that they are ill to bribing doctors and misrepresenting the results of safety and efficacy tests on their products. In a report that charts the scale of illicit practices by drug companies in the UK and across Europe, Consumers International - the world federation of consumer organisations - says people are not being given facts about the medicines they take because the companies hide the marketing tactics on which they spend billions. "Irresponsible marketing practices form a serious, persistent and widespread problem among the entire pharmaceutical industry," says the report, which analyses the conduct of 20 of the biggest companies, two of which are British. It calls for tougher government controls and for the companies to put their house in order. Scandals such as the withdrawal of Vioxx, a drug to relieve pain and inflammation in arthritis, show that unethical drug promotion is a consumer concern, says the report. Merck withdrew the drug in September 2004, but allegedly knew it could increase the chances of heart attacks and strokes from 2000 and has been accused of manipulating study results to play down the risk. More than 6,000 lawsuits have been filed against the company in the United States by people who claim they suffered heart attacks as a result of the drug, or by their families. Despite regulatory action against drug companies, the malpractice continues, says CI. Many people in the UK may feel they are secure because they trust their doctors to tell them which drug to take, but CI says there is no room for complacency when drug companies spend twice as much on marketing as on research - $60bn last year (£33bn) - but do not publish information on their drug promotion practices. Of the 20 companies, only Bristol-Myers Squibb provides a marketing code of conduct to consumers. "One obvious area of concern is about how the promotion of drugs by the pharmaceutical companies to doctors can lead to irrational drug use," says Richard Lloyd, CI's director general. "There is a lot of evidence around of malpractice. This report has found that it is still going on and in a big way and it must be stopped." More than half the companies looked at were implicated in controversies regarding their relationships to healthcare professionals between 2001 and 2005, says the report. The British company AstraZeneca, for instance, has been criticised by regulatory bodies: it allegedly organised an event to promote its drug Crestor which included tickets for a musical, and provided flights and hotels for doctors to attend a conference on bipolar disorder on the French Riviera. AstraZeneca says all employees must now pass an exam on its code of conduct. GlaxoSmithKline, Britain's largest drug manufacturer, is under investigation by German and Italian authorities for alleged corruption of doctors - at least 1,600 in Germany and more than 4,000 in Italy, where the illegal gifts were said to amount to 228m (£156m) from 1999 to 2002. GSK says it has since established marketing codes. New staff have to pass a test on the code of practice. The report points out that in 2004, 87 employees were dismissed or agreed to leave the company voluntarily as a result of breaches of the codes, and that sanctions such as written warnings were imposed in 109 cases. | harry punter | |
07/3/2007 04:33 | Financial Services Authority (FSA) 25 The North Colonnade Canary Wharf E14 5HS Internet Address: www.fsa.gov.uk Tel:0845 606 1234 (Public Helpline) Minicom: Fax:020 7676 9713 Email: consumerhelp@fsa.gov 7th March 2007 Dear sirs - Having previously been personally vetted and investigared on tape --i now expect your organisation to act on the information that i will continue to provide in the form of letters e-mails also postings on public bulleton boards - some usefull back ground information will accompany my public compliants as this course of action will -i am confident bring a successful criminal case against Gary Amos ,Catherine Tan and Steve Regan -- i am instigating with the help and full co-operation of the Department of Trade and Industry -criminal charges against the London and Monaco Stock market Mafia together with several other City white collar and blue collar criminals -- I have supplied your organisation already with all the names and relevant facts on individuals together with my own personal, accurate and detailed records that fortunately i kepted over these past years -- i agree to supply evidence against only those that i have already publicly named on these advfn threads -- i expect to see all of my personal complaints dealt with immediately---as my evidence will lead to and secure criminal convictions against these offenders -- i am complaining as a private citizen and also as a stock exchange practioner --many charges and complaints relate directly and indirectly to the partial theft of my own property --therefore i demand my legal rights that the FSA investigate these official complaints of mine regards harry punter | harry punter | |
07/3/2007 04:14 | off topic -- ZincOx Resources - ex Reunion team recycling slag. heaps of potential & risk (ZOX) harry punter - 7 Mar'07 - 04:13 - 631 of 631 edit imho this is the bottom punters looking at that chart --c/p 275p next price 400p ---- \o/ enjoy the trip | harry punter | |
07/3/2007 03:35 | -and when minster gets a nasdaq listing - what price then vuelands ??? | harry punter | |
06/3/2007 20:00 | Watch it drop like a stone after consolidation. | vuelands |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions